rodarohw case-acs dynamics nstemi to stemi management and prognosis

Upload: robin-h-wibowo

Post on 01-Jun-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    1/40

    R.D. Robi

    * ACS ProgressionNSTEMI to STEMI

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    2/40

    CounselorDr. H. A. Fauzi Yahya., Sp. JP. (K), FIHA.

    by RD. Robin H Wibowo

    *

    Case Report Presentation

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    3/40

    *

    Case Presentation

    Case discussion

    Conclusion

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    4/40

    * General information

    * A male patient, TW, 59 years old

    * Retired go ernment employee

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    5/40

    Clinical History

    !mo"ing

    Dyslipidemia

    #eit$er

    C$est pain!%& $istory

    C$est pain5 Hourbe'ore

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    6/40

    * Physical Examinat()P 5*+cmH %

    H(R -*

    Kardiomegali -/

    !0 normal, !normal, !+ -/ !1 -/2urmur -/Rales -*3* 03+

    4dema -/Warm -*3*

    &P 00 36 mmHg,regular $eart rateo' 67 bpm,RR 1 8!a% 97

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    7/40

    * a!oratory "in#in

    Hb : 11,1 : 36 #a : 139 ?D! :

    Tr : 255000 = : 4,0

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    8/40

    *

    Ele$tro$ar#io

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    9/40

    *

    Rontgen th

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    10/40

    * %iag

    *

    NSTEMI& 'illip II* T@2@ 36* ?RAC4 059

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    11/40

    *

    Treat

    * &R, % + liter3menit, Hepcup* Diet antung @ 05 ""al3$ari, protein 0 gr3"g&&3$ari, =H:> 7 :1* Aspilets loading dose 07 mg, dilan ut"an 08B0 mg po*

    Clopidogrel loading dose + mg, dilan ut"an 0865 mg po* @!D# 5 mg !> prn* Heparinisasi dengan 4no8aparin 8 ,7 cc sc* Rencana angiografi $oroner #an a# hoc PCI (early)* "urosemi#e *x+, mg i- target !alance ./,,.0,,, cc1*+ 2am* %ia3epam ,.,./ mg* axa#ine ,.,.0/ mg* Ator-astatin ,.,.+, mg* Peri$sa profil lipi#& G%P& G% *4PP& asam urat* Peri$sa E'G serial1*+ 2am atau !ila nyeri #a#a* Rencana echocar#iografi* Ra5at I6C1I7

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    12/40

    Clinical History

    Admisson

    nd Day

    PersistentC$est Pain

    +rd DayC$est Pain

    Worsened&reat$lessnes

    s

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    13/40

    *

    Ele$tro$ar#io@

    @@

    @@@

    5

    0

    05

    5

    +

    +5

    +5

    e-els

    C'M8

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    14/40

    * Acute 48tensi e Anterior !T42@

    =illip @@@

    PrimaryPCI

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    15/40

    * Angiogra

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    16/40

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    17/40

    Clinical History

    Admisson

    +rd Day

    PrimaryPC@

    6t$ DayDisc$arge

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    18/40

    *

    Case Presentation

    Case discussion

    Conclusion

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    19/40

    * O-e

    *

    * #CCH=, data 'rom 9/ 00 s$owed t$erewas 5 5 !T42@ patients -+5 , 0761 #!T42@patients - + , and 99

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    20/40

    * %efini

    2yocardial in'arction -2@ is deFned in pat$ology AC! spectrum -

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    21/40

    * Anderson (>, Adams CD, Antman 42, et al. ACC3AHA 6 ?uidelines 'or t$e 2anagement o' Patients Wit$

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    22/40

    Anderson (>, Adams CD, Antman 42, et al. ACC3AHA 6 ?uidelines 'or t$e 2anagement o' Patients Wit$

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    23/40

    * #!T42@ is an unstable coronary conditionprone to isc$emic recurrences and ot$ercomplications

    * T$e ?RAC4 study s$owed B/0 o' #!T42@patients will $a e recurrent angina wit$ !Tsegment c$anges on $ospitaliJation.

    * Anderson (>, Adams CD, Antman 42, et al. ACC3AHA 6 ?uidelines 'or t$e 2anagement o' Patients Wit$

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    24/40

    * Ris$ Stratification for 9A1NS

    * @mportant in management* Determines t$e c$oice o' management*

    4stimating prognosis* !e eral ris" scores predicting ris" Widely used =illip, T@2@ and ?RAC4 score

    * Anderson (>, Adams CD, Antman 42, et al. ACC3AHA 6 ?uidelines 'or t$e 2anagement o' Patients Wit$

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    25/40

    =illip Classi'ication o' A2@=illip Classi'ication o' A2@

    Absence o' !+ gallop rales

    Class I

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    26/40

    T@2@ 00&

    TIMI Risk Score for UA/ ST!MI

    % "/MI/Ur#e$ Re&'sc()'ri*' io$ +s TRS

    A$ '$ !M, -AMA 2000.284 83

    $e oof

    A >

    ' r

    50 ST >

    e& A !)

    M

    4arly Ris" !trati'ication4arly Ris" !trati'ication

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    27/40

    T@2@ 06

    TIMI Risk Score for ST!MI

    Mor ')i ' 30 7 &s ST!MI TRS

    Morro: "A, irc()' io$ 2000.102 203

    ;is oric')A#e 65 4

    > 53"M/;T /A$#i

    !='S < 100 ;R > 100 ?@i))i II I+

    ei# < 6

    rese$ ' io$A$ erior ST

    B Ti e o R= >

    Risk Score C

    4arly Ris" !trati'ication4arly Ris" !trati'ication

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    28/40

    o e$7i( of A?ri7#e7 !S F(i7e)i$es 2008, ?lobal Registry o' Acute Coron

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    29/40

    * In-asi-e -ersus conser-ati-e approach

    * 2eta/analysis -&a ry et al E signiFcant ris" reduction 'or all caumortality and non/'atal 2@ 'or an early in asi e approac$ at years wit$out an e8cess o' deat$ and non/'atal 2@ at 0 mont$

    * 2eta/analysis -% Donog$ue et al E signiFcant reduction in deat$2@, or re$ospitaliJation wit$ AC! 'or in asi e strategy at 0 year

    * 2eta/analysis - o8 et al E re ealed a reduction in rates o' deat$and non/'atal 2@ at 5/year 'ollow/up, wit$ t$e most pronounceddi''erence in $ig$ ris" patients -00,0 .

    * &a ry AA, =umb$ani D(, Rassi A#, et al. &eneFt o' early in asi e t$erapy in acute coronary syndromes: a meta/analysis o' contemporary randomiJed clinical trials. ( Am Coll Cardiol7E1B:0+09I0+ 5.

    * %ODonog$ue 2, &oden W4, &raunwald 4,et al. 4arly in asi e s conser ati e treatment strategies in women and men wit$ unstable angina and non/!T/segment ele ation myocardialin'arction: a meta/analysis. (A2A BE+ :60IB .

    * o8 =A, Clayton TC, Damman P, et al. >ong/term outcome o' a routine ersus selecti e in asi e strategy in patients wit$ non/!T/segment ele ation acute coronary syndrome a meta/analysis o' indi idual pati ent data. ( Am Coll Cardiol 0 E55: 1+5I 115.

    6ighlight the role of ris$

    strati;cation

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    30/40

    * Timing of angiography an# inter-entio

    The TIMACS trial* !igniFcant reduction in deat$, 2@, or stro"e at 7 mont$s

    in $ig$ ris" #!T42@ patients -?RAC4 score L01 , wit$ early -K 1 $ compared wit$ a delayed strategy.* Howe er, t$ere was not signiFcant di''erence wasobser ed in patients wit$ a low to intermediate ris"proFle -?RAC4 score K01 .

    2e$ta !R, ?ranger C&, &oden W4, et al. 4arly ersus delayed in asi e inter ention in acute coronary syndromes. # 4ngl ( 9E+7 : 075I 065

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    31/40

    Anderson (>, Adams CD, Antman 42, et al. ACC3AHA 6 ?uidelines 'or t$e 2anagement o' Patie

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    32/40

    * STEMI an# NSTEMI& is it #iffe

    * 2ortality L !T42@ t$an #!T42@ -6 s.+I5 ,respecti ely , but 7/mont$s mortality rates are erysimilar -0 and 0+ , respecti ely

    * Opera registry s$owed comparable result* >ongterm obser ational study 'ound t$at deat$ rates

    L#!T42@ t$an wit$ !T42@E 8 at 1 years

    e$ RW, !idney !, C$andra 2, et al. Population trends in t$e incidence and outcomes o' acute myocardial in'arction. # 4ng2ed 0 E +7 : 055I 075

    2andelJweig >, &attler A, &oy"o ), et al. T$e second 4uro Heart !ur ey on acute coronary syndromes: c$aracteristics,treatment, and outcome o' patients wit$ AC! in 4urope and t$e 2editerranean &asin in 1. 4ur Heart ( 7E 6: B

    Ter"elsen C(, >assen ( , #orgaard &>, et al. 2ortality rates in patients wit$ !T/ele ation s.non/!T/ele ation acutem ocardial in'arction: obser ations 'rom an unselected co$ort. 4ur Heart ( 5 7:0BI 7

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    33/40

    ?iles, et al. !T42@ and #!T42@ : are t$ey so di''erent %P4RA registry real/world data 'rom t$e 4uropean PubliHealt$ %utcome Researc$ and @ndicators Collection Pro ect. Arc$ @ntern 2ed 0 E06 :BBBIB95

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    34/40

    urman 2@, Dauerman H>, ?oldberg R(, et al. Twenty/two year -0965 to 0996 trends in t$e incidence, in/$ospital anterm case 'atality rates 'rom initial Q/wa e and non/Q/wa e myocardial in'arction: a multi/$ospital, community/wideperspecti e. ( Am Coll Cardiol 0E+6:0560/B

    More attentionto NSTEMI

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    35/40

    * Treatm

    !c$iele study 'ound 00 N in mortality 30increase in ad$erence to ACC and AHA guidelines

    ?AP -T$e ?uidelines Applied in Practice study'ound t$at ris" o' deat$ wit$in a year was 5lower a'ter disc$arge i' $ospitals 'ollowed nationalguidelines

    !c$iele , 2ene eau #, !eronde 2 , et al. Compliance wit$ guidelines and 0/year mortality in patients wit$ acutmyocardial in'arction: a prospecti e study. 4ur Heart ( 5E 7:B6+/B .

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    36/40

    *

    Case Presentation

    Case discussion

    Conclusion

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    37/40

    * Conc

    * We reported a case o' male patient, 2r TW, 59 yo, w$omwas diagnosed as #!T42@ T@2@ ris" 36 grace score 019,=illip @@. During e aluation, $is myocardial in'arction

    e ol ed to !T42@. He was treated wit$ primary PC@, wit$good results.

    * AC! represent a p$ysiologic continuum spanning o'unstable angina, non/!T ele ation myocardial in'arctionand !T ele ation myocardial in'arction.

    * T$e management must begin wit$ ris" strati'ication,'ollowed wit$ t$erapy according to guidelines, and goode aluation during $ospital care and a'ter disc$arge.

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    38/40

    * Ta$e 6ome Messa

    ?ood prior e aluation ?ood inter ention

    !tate o' t$e art monitoring 'ollow up

    !a e muscleOs, !a e li es

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    39/40

    Gracias

  • 8/9/2019 RoDaroHW Case-ACS Dynamics NSTEMI to STEMI Management and Prognosis

    40/40